Encapsulation of 5-aminosalicylic acid into Eudragit RS microspheres and modulation of their release characteristics by use of surfactants
- 31 August 1991
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 16 (3), 311-318
- https://doi.org/10.1016/0168-3659(91)90008-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Polyacrylate (Eudragit Retard) Microspheres for Oral Controlled Release of Nifedipine. I. Formulation Design and Process OptimizationDrug Development and Industrial Pharmacy, 1990
- Newer 5-Aminosalicylic Acid Based Drugs in Chronic Inflammatory Bowel DiseaseDrugs, 1989
- Design and release kinetic pattern evaluation of indomethacin microspheres intended for oral administrationBiomaterials, 1988
- A New Approach to the Oral Administration of Insulin and Other Peptide DrugsScience, 1986
- Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Eudragit E, L and S (acrylic resins) microcapsules as pH sensitive release preparations of ketoprofenJournal of Microencapsulation, 1986
- Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic modelJournal of Pharmacy and Pharmacology, 1985
- Drug glycosides: potential prodrugs for colon-specific drug deliveryJournal of Medicinal Chemistry, 1984
- Preparation and Evaluation of Controlled Release Indomethacin MicrospheresDrug Development and Industrial Pharmacy, 1984
- Colonic release of 5‐amino salicylic acid from an oral preparation in active ulcerative colitis.British Journal of Clinical Pharmacology, 1983